Creyon Bio Secures U.S. Patent for AI-Driven Platform

By Daniella Parra Creyon Bio has received a U.S. patent for its AI-driven platform that designs safer and more effective oligonucleotide-based medicines (OBMs), it said. This company said the platform’s success includes advancing a program from concept to patient treatment...